On September 16, 2021 Valo Health, LLC ("Valo"), the technology company built to transform the drug discovery and development process using human-centric data and artificial intelligence driven compute, reported that its CEO and founder, David Berry, is participating on the "Tech Solutions: a Biotech Perspective" panel at the BofA Securities 2021 Virtual Tech Solutions for Drug Discovery Conference on September 20, 2021 at 9:00 AM Eastern Time (Press release, Valo Health, SEP 16, 2021, View Source [SID1234587851]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The pre­sen­ta­tion will be web­cast live and avail­able for replay on the investor rela­tions page of the Valo web­site.